Roberto Blanco Sequeiros

University of Turku, Turku University Hospital

Papers

Total Citations

H-Index

About

Roberto Blanco Sequeiros is a leading radiologist and researcher whose work centers on advancing minimally invasive, image-guided therapies for prostate cancer. His primary research areas include interventional MRI, prostate cancer ablation, and the development of novel therapeutic techniques that integrate high-resolution imaging with precise thermal treatment. Dr. Sequeiros has made pivotal contributions to the clinical application of MRI-guided transurethral ultrasound ablation (TULSA), a cutting-edge procedure that offers a targeted alternative to whole-gland therapies. His landmark 2019 study, which has garnered over 30 citations, established the feasibility and safety of lesion-targeted TULSA for organ-confined prostate cancer, demonstrating high accuracy in inducing cell death while minimizing toxicity. Building on this, his 2020 work provided the first detailed characterization of acute and subacute MRI findings following TULSA, offering crucial insights into post-treatment tissue response and imaging follow-up protocols. These contributions have helped shape the emerging paradigm of focal therapy, positioning Dr. Sequeiros as a key figure in the transition toward more personalized, less invasive cancer care. His research continues to influence both clinical practice and the development of next-generation ablation technologies.